Learn
Medical EducationEvidence-Based MedicinePatient Education
ICU Toolkit
CalculatorsProtocols & CardsICU Setup
CPT & BillingZad TalkForumContact
Home / Calculators / Murray Lung Injury Score Calculator

Murray Lung Injury Score Calculator

The Murray Lung Injury Score grades acute lung injury from four findings, each scored 0 to 4 and averaged. A score of 3.0 or more was the lung injury entry criterion in the protocol of the CESAR ECMO trial.

Murray Lung Injury Score
Fill in the fields above to see the result.

How to read the result

ScoreMeaning in the CESAR trial
2.5 or lessBelow the CESAR thresholds
2.75Above 2.5: early registration and discussion of ECMO referral allowed
3.0 to 4.0Entry criterion for referral to an ECMO center, on optimal conventional care

The CESAR protocol calls 3.0 a minimum entry criterion, while the trial report and the ELSO VV guideline describe the threshold as above 3.0; this calculator puts 3.0 in the entry band. With all four components the score moves in steps of 0.25. CESAR also took patients with uncompensated hypercapnia and a pH below 7.20, whatever their score. The ELSO 2021 VV-ECMO guideline lists a Murray score above 3 (CESAR) and a PaO2/FiO2 below 80 mmHg (EOLIA) as trial thresholds for starting VV-ECMO, with no strong data that either is better, and suggests using the Murray and RESP scores together when deciding on VV-ECMO and transfer.

Scoring

PointsChest X-ray: quadrants with consolidationPaO2/FiO2 (mmHg)PEEP (cmH2O)Compliance (mL/cmH2O)
0None300 or more5 or less80 or more
11225-2996-860-79
22175-2249-1140-59
33100-17412-1420-39
44Below 10015 or more19 or less

Score = sum of the four component points ÷ 4. This calculator needs all four components, as the CESAR and START trial protocols did. Static compliance is tidal volume divided by plateau pressure minus PEEP; the CESAR protocol used peak inspiratory pressure in place of plateau. P/F in kPa × 7.5 gives mmHg; CESAR measured it on FiO2 1.0 for at least 20 minutes.

Validation

Murray and colleagues proposed the score in 1988 as part of an expanded definition of ARDS. In the CESAR trial, 180 adults aged 18-65 with a score above 3.0 or a pH below 7.20 were randomized; 63% of those referred for consideration of ECMO survived to 6 months without severe disability, against 47% with conventional management (relative risk 0.69). The CESAR protocol and the START protocol (an ARDS trial led by one of the original authors) give the same cut-offs and divide by four.

References

  1. Murray JF, Matthay MA, Luce JM, et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720-723. PMID 3202424
  2. Peek GJ, Clemens F, Elbourne D, et al. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv Res. 2006;6:163. PMID 17187683
  3. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351-1363. PMID 19762075
  4. Matthay MA. Human mesenchymal stromal cells for acute respiratory distress syndrome (START): clinical study protocol, Appendix B: Lung Injury Score. ClinicalTrials.gov; 2015. NCT02097641
  5. Tonna JE, Abrams D, Brodie D, et al. Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): guideline from the Extracorporeal Life Support Organization (ELSO). ASAIO J. 2021;67(6):601-610. PMID 33965970
Keep reading

Related articles

All Pulmonary →